Literature DB >> 15798092

Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation.

Chad J Creighton1, Jennifer L Bromberg-White, David E Misek, David J Monsma, Frank Brichory, Rork Kuick, Thomas J Giordano, Weimin Gao, Gilbert S Omenn, Craig P Webb, Samir M Hanash.   

Abstract

Tumor cell lines are relied on extensively for cancer investigations, yet cultured cells in an in vitro environment differ considerably in behavior compared with those of the same cancer cells that proliferate and form tumors in vivo. To uncover gene expression changes related to tumor formation, gene expression profiles of human lung adenocarcinoma (A549) cells grown as lung tumors in immune-compromised mice were compared with profiles of the same cells grown in vitro. Additionally, profiles of uninvolved adjacent mouse tissue were determined. A profound interplay between cancer cells and the host was shown that affected a complex protein interaction network involving processes of extracellular interaction, growth factor signaling, hemostasis, immune response, and transcriptional regulation. Growth in vivo of A549 cells, which carry an activating k-ras mutation, induced changes in gene expression that corresponded highly to a pattern characteristic of human lung tumors with k-ras mutation. Cytokines interleukin-4, interleukin-6, and IFN-gamma each induced distinct in vitro genomic responses in cancer cells that emulated many of the changes in gene expression observed in vivo. Genes that were both selectively induced in vivo and overexpressed in human lung adenocarcinoma tumors included CSPG2, which has not been associated previously with tumor formation. Knockdown in A549 of CSPG2 by RNA interference significantly inhibited tumor growth in vivo but not in vitro. Thus, analysis of tumor xenografts by gene expression profiling has the potential for identifying genes involved in tumor development that may not be expressed in cancer cells grown in vitro.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798092     DOI: 10.1158/1541-7786.MCR-04-0189

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  27 in total

1.  Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation.

Authors:  Konstantin Knoblich; Hong-Xing Wang; Chandan Sharma; Anne L Fletcher; Shannon J Turley; Martin E Hemler
Journal:  Cell Mol Life Sci       Date:  2013-08-18       Impact factor: 9.261

2.  Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.

Authors:  Narayan Shivapurkar; Victor Stastny; Naoki Okumura; Luc Girard; Yang Xie; Clemens Prinsen; Frederik B Thunnissen; Ignacio I Wistuba; Bogdan Czerniak; Eugene Frenkel; Jack A Roth; Triantafillos Liloglou; George Xinarianos; John K Field; John D Minna; Adi F Gazdar
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

3.  Robust global microRNA expression profiling using next-generation sequencing technologies.

Authors:  Shirley Tam; Richard de Borja; Ming-Sound Tsao; John D McPherson
Journal:  Lab Invest       Date:  2014-01-20       Impact factor: 5.662

4.  Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha.

Authors:  Ash A Alizadeh; Sean P Bohen; Chen Lossos; Jose A Martinez-Climent; Juan Carlos Ramos; Elena Cubedo-Gil; William J Harrington; Izidore S Lossos
Journal:  Leuk Lymphoma       Date:  2010-07

Review 5.  Microenvironmental regulation of cancer development.

Authors:  Min Hu; Kornelia Polyak
Journal:  Curr Opin Genet Dev       Date:  2008-02-20       Impact factor: 5.578

6.  Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia.

Authors:  Amy L Samuels; Violet K Peeva; Rachael A Papa; Marin J Firth; Richard W Francis; Alex H Beesley; Richard B Lock; Ursula R Kees
Journal:  BMC Genomics       Date:  2010-04-21       Impact factor: 3.969

7.  In-vivo transfection of pcDNA3.1-IGFBP7 inhibits melanoma growth in mice through apoptosis induction and VEGF downexpression.

Authors:  Rong-Yi Chen; Hong-Xiang Chen; Jia-Xi Lin; Wei-Bing She; Ping Jiang; Li Xu; Ya-Ting Tu
Journal:  J Exp Clin Cancer Res       Date:  2010-02-16

8.  Insulin-like growth factor binding protein 7 mediates glioma cell growth and migration.

Authors:  Wei Jiang; Cunli Xiang; Simona Cazacu; Chaya Brodie; Tom Mikkelsen
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

9.  Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability.

Authors:  Cynthia A Pise-Masison; Michael Radonovich; Kathleen Dohoney; John C Morris; Deirdre O'Mahony; Min-Jung Lee; Jane Trepel; Thomas A Waldmann; John E Janik; John N Brady
Journal:  Blood       Date:  2009-01-08       Impact factor: 22.113

10.  mtDNA depletion confers specific gene expression profiles in human cells grown in culture and in xenograft.

Authors:  Darren Magda; Philip Lecane; Julia Prescott; Patricia Thiemann; Xuan Ma; Patricia K Dranchak; Donna M Toleno; Krishna Ramaswamy; Kimberly D Siegmund; Joseph G Hacia
Journal:  BMC Genomics       Date:  2008-11-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.